Insider Transactions in Q1 2021 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,330
+2.06%
|
-
|
|
Jan 21
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,372
-2.92%
|
$182,644
$77.43 P/Share
|
|
Jan 21
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,353
+6.17%
|
-
|
|
Jan 21
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,462
-37.27%
|
$189,574
$77.43 P/Share
|
|
Jan 21
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,556
+45.69%
|
-
|
|
Jan 21
2021
|
Jeff Kent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,349
-1.89%
|
$103,873
$77.43 P/Share
|
|
Jan 21
2021
|
Jeff Kent Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,045
+4.09%
|
-
|
|
Jan 21
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-1.49%
|
$198,506
$77.43 P/Share
|
|
Jan 21
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,819
+3.26%
|
-
|
|
Jan 21
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Payment of exercise price or tax liability
|
Direct |
1,772
-1.96%
|
$136,444
$77.43 P/Share
|
|
Jan 21
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Exercise of conversion of derivative security
|
Direct |
3,999
+4.23%
|
-
|
|
Jan 21
2021
|
Vikram Karnani EVP & President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
2,173
-1.87%
|
$167,321
$77.43 P/Share
|
|
Jan 21
2021
|
Vikram Karnani EVP & President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
4,904
+4.05%
|
-
|
|
Jan 21
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,824
-1.54%
|
$140,448
$77.43 P/Share
|
|
Jan 21
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,678
+3.01%
|
-
|
|
Jan 21
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-1.91%
|
$128,282
$77.43 P/Share
|
|
Jan 21
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+4.13%
|
-
|
|
Jan 21
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,826
-1.48%
|
$140,602
$77.43 P/Share
|
|
Jan 21
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,120
+3.23%
|
-
|
|
Jan 21
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,591
-4.52%
|
$122,507
$77.43 P/Share
|
|
Jan 21
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,590
+9.25%
|
-
|
|
Jan 21
2021
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,427
-3.07%
|
$109,879
$77.43 P/Share
|
|
Jan 21
2021
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,220
+6.48%
|
-
|
|
Jan 19
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Bona fide gift
|
Indirect |
169,132
+38.34%
|
-
|
|
Jan 19
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
169,132
-99.38%
|
-
|
|
Jan 15
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
211,204
-6.37%
|
$16,473,912
$78.21 P/Share
|
|
Jan 06
2021
|
Vikram Karnani EVP & President, International |
SELL
Open market or private sale
|
Direct |
30,031
-21.23%
|
$2,252,325
$75.0 P/Share
|
|
Jan 06
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
27,106
-19.12%
|
$2,032,950
$75.0 P/Share
|
|
Jan 06
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
27,106
+9.1%
|
$433,696
$16.06 P/Share
|
|
Jan 06
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
26,844
-6.33%
|
$1,959,612
$73.63 P/Share
|
|
Jan 05
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,597
-11.76%
|
$116,581
$73.28 P/Share
|
|
Jan 05
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,386
+19.95%
|
-
|
|
Jan 05
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
337,380
-22.57%
|
$24,628,740
$73.28 P/Share
|
|
Jan 05
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
492,294
+24.77%
|
-
|
|
Jan 05
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
269,057
+21.15%
|
-
|
|
Jan 05
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,256
-34.83%
|
$3,303,688
$73.28 P/Share
|
|
Jan 05
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,313
+31.7%
|
-
|
|
Jan 05
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,615
+37.41%
|
-
|
|
Jan 05
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
134,698
-44.18%
|
$9,832,954
$73.28 P/Share
|
|
Jan 05
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
205,638
+40.28%
|
-
|
|
Jan 05
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
98,192
+49.73%
|
-
|
|
Jan 05
2021
|
Jeff Kent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,997
-16.98%
|
$1,021,781
$73.28 P/Share
|
|
Jan 05
2021
|
Jeff Kent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,822
+7.64%
|
-
|
|
Jan 05
2021
|
Jeff Kent Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,549
+24.51%
|
-
|
|
Jan 05
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
44,185
-27.02%
|
$3,225,505
$73.28 P/Share
|
|
Jan 05
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
60,313
+26.94%
|
-
|
|
Jan 05
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
39,196
+27.52%
|
-
|
|
Jan 05
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
52,858
-24.05%
|
$1,902,888
$36.1 P/Share
|
|
Jan 05
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,089
+22.85%
|
-
|
|
Jan 05
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
54,003
+25.87%
|
-
|